Skip to main content
Livermore
Livermore
ZHEN

DAGCO, Inc.

SEC CIK
0001767343
Latest filing
Jul 10, 2026

ABT holding history

Abbott Laboratories in every 13F filed by DAGCO, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
6,073
Value
$551.0K
% of portfolio
0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by DAGCO, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20266,073$551.0K0.1%−974−13.8%ReducedHolders
Q1 20267,047$723.5K0.2%−447−6.0%ReducedHolders
Q4 20257,494$939.0K0.2%−874−10.4%ReducedHolders
Q3 20258,368$1.12M0.3%+40.0%AddedHolders
Q2 20258,364$1.14M0.3%+424+5.3%AddedHolders
Q1 20257,940$1.05M0.3%−75−0.9%ReducedHolders
Q4 20248,015$906.6K0.3%+390+5.1%AddedHolders
Q3 20247,625$869.3K0.4%−75−1.0%ReducedHolders
Q2 20247,700$800.1K0.4%00.0%UnchangedHolders
Q1 20247,700$875.2K0.4%+6,765+723.5%AddedHolders
Q4 2023935$102.9K0.1%−7,665−89.1%ReducedHolders
Q3 20238,600$832.9K0.5%00.0%UnchangedHolders
Q2 20238,600$937.6K0.5%00.0%UnchangedHolders
Q1 20238,600$870.8K0.5%00.0%UnchangedHolders
Q4 20228,600$944.2K0.6%00.0%UnchangedHolders
Q3 20228,600$832.0K0.5%−350−3.9%ReducedHolders
Q2 20228,950$972.0K0.5%00.0%UnchangedHolders
Q1 20228,950$1.07M0.5%−90−1.0%ReducedHolders
Q4 20219,040$1.27M0.5%−285−3.1%ReducedHolders
Q3 20219,325$1.10M0.5%−120−1.3%ReducedHolders
Q2 20219,445$1.09M0.5%00.0%UnchangedHolders
Q1 20219,445$1.13M0.6%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.